7Baggers
Quarterly
Annual
    Unit: USD2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 
                         
      cash flows from operating activities
    		                     
      net loss
    		-32,213,000 -68,433,000 -48,360,000 -40,018,000 -62,299,000 -57,326,000 -72,189,000 -63,722,000 -62,398,000 -61,750,000 -71,414,000 -61,468,000 -95,026,000 -100,905,000 -112,969,000 -98,868,000 -90,049,000 -69,280,000 -68,355,000 -60,658,000 -61,510,000 
      adjustments to reconcile net loss to net cash from operating activities:
    		                     
      allowance for expected credit losses
    		276,000 399,000 166,000 1,027,000 2,165,000 653,000 173,000 199,000 1,068,000 683,000 652,000 737,000  -315,000        
      depreciation and amortization
    		6,119,000 5,809,000 5,146,000 4,963,000 4,813,000 4,437,000 4,279,000 4,014,000 3,937,000 3,531,000 3,588,000 3,288,000 3,162,000 3,204,000 3,199,000 3,104,000 2,963,000 3,129,000 1,399,000 973,000 978,000 
      amortization of deferred contract acquisition costs
    		7,044,000 7,036,000 7,078,000 6,691,000 6,718,000 6,696,000 6,406,000 6,087,000 6,001,000 5,668,000 5,432,000 4,871,000 4,589,000 3,937,000 3,527,000 3,045,000 2,708,000 2,317,000 1,993,000 1,629,000 1,395,000 
      stock-based compensation expense
    		49,776,000 54,746,000 62,154,000 48,167,000 50,569,000 51,955,000 60,107,000 48,640,000 51,849,000 52,866,000 56,205,000 41,498,000 53,128,000 47,991,000 47,934,000 39,909,000 42,267,000 25,848,000 20,381,000 16,031,000 15,926,000 
      net accretion of discount on marketable securities
    		-412,000 -439,000 -542,000 -736,000  -1,090,000 -1,725,000 -1,831,000          115,000 250,000 336,000  
      non-cash lease expense
    		4,577,000 4,566,000 4,582,000 4,540,000 4,439,000 4,640,000 4,436,000 4,452,000 4,092,000 3,954,000 4,781,000 5,263,000 4,169,000 4,058,000 3,729,000 3,639,000 3,347,000 4,462,000 4,254,000 4,526,000 4,554,000 
      impairment of long-lived assets
    		0        0 0            
      amortization of discount on revolving credit facility and term loan issuance costs
    		31,000 31,000 30,000 30,000 31,000 30,000 31,000 30,000  31,000 30,000 30,000          
      changes in operating assets and liabilities:
    		                     
      accounts receivable
    		-37,848,000 -3,391,000 -971,000 18,738,000 -25,271,000 -2,304,000 34,646,000 -11,732,000 -21,778,000 -2,407,000 31,910,000 -17,252,000 -23,802,000 -6,580,000 13,734,000 -8,531,000 -13,014,000 -12,979,000 2,182,000 -3,182,000 -8,627,000 
      prepaid expenses and other current assets
    		-4,112,000 -4,532,000 -11,333,000 -8,846,000 -4,575,000 -2,254,000 -9,196,000 -4,402,000 -11,830,000 -4,707,000 -4,432,000 -4,625,000 -1,887,000 5,547,000 -15,899,000 -11,803,000 -14,664,000 -3,417,000 -3,188,000 -2,383,000 -3,933,000 
      other assets
    		-1,192,000 287,000 988,000 -714,000 194,000 -1,513,000 -2,187,000 -894,000 -1,210,000 -606,000 467,000 881,000 -907,000 -1,178,000 173,000 -2,196,000 -4,371,000 -2,842,000 -1,653,000 -1,858,000 -853,000 
      accounts payable
    		4,708,000 -3,652,000 7,985,000 -1,724,000 -167,000 -1,759,000 -77,000 6,446,000 -4,181,000 6,857,000 -3,231,000 -14,000 -1,058,000 -1,864,000 -6,150,000 4,681,000 -1,804,000 7,371,000 4,143,000 -2,451,000 -4,717,000 
      accrued expenses and other liabilities
    		8,244,000 7,334,000 -4,728,000 -7,442,000 18,012,000 -5,035,000 3,810,000 -10,183,000 11,679,000 -2,668,000 -800,000 -13,417,000 10,314,000 -1,258,000 15,692,000 791,000      
      deferred revenue
    		28,727,000 -8,494,000 23,332,000 -12,512,000 20,661,000 -7,050,000 -7,881,000 25,851,000 15,780,000 -5,693,000 -2,814,000 30,350,000 18,761,000 4,665,000 8,148,000 27,801,000 19,512,000 15,157,000 13,645,000 20,025,000 15,738,000 
      operating lease liabilities
    		-6,135,000 -5,811,000 -5,692,000 -5,400,000 -5,356,000 -4,970,000 -4,775,000 -4,853,000 -6,554,000 -3,356,000 -4,663,000 -4,291,000 -3,455,000 -3,478,000 -3,505,000 -3,391,000 -401,000 3,923,000 -1,823,000 6,364,000 7,884,000 
      net cash from operating activities
    		27,590,000 16,172,000 39,835,000 6,764,000 15,855,000 -14,890,000 15,858,000 -1,898,000 -15,337,000 -8,233,000 20,232,000 -14,593,000 -31,099,000 -46,178,000 -41,648,000 -41,133,000 -39,325,000 -28,500,000 -8,516,000 -7,444,000 -18,165,000 
      capital expenditures
    		-3,414,000 -2,743,000 -4,453,000 -2,769,000 -3,516,000 -3,291,000 -3,098,000 -2,377,000 -1,615,000 -3,232,000 -5,627,000 -2,687,000 -3,065,000 -2,339,000 -635,000 -1,118,000 -1,284,000 -10,937,000 -12,701,000 -17,152,000 -22,295,000 
      free cash flows
    		24,176,000 13,429,000 35,382,000 3,995,000 12,339,000 -18,181,000 12,760,000 -4,275,000 -16,952,000 -11,465,000 14,605,000 -17,280,000 -34,164,000 -48,517,000 -42,283,000 -42,251,000 -40,609,000 -39,437,000 -21,217,000 -24,596,000 -40,460,000 
      cash flows from investing activities
    		                     
      purchases of marketable securities
    		-18,078,000 -56,981,000 -70,041,000 -34,055,000 -67,820,000 -59,502,000 -36,642,000 -70,484,000 -34,821,000 -145,018,000 0 -139,294,000 0 2,000 -25,664,000 -46,554,000 -471,000 -13,453,000 -14,468,000 -34,002,000 -64,963,000 
      sales of marketable securities
    		        6,000        22,000 0 0 351,000  
      maturities of marketable securities
    		40,688,000 69,000,000 55,576,000 41,000,000 44,996,000 104,309,000 39,796,000 51,500,000 17,500,000 7,500,000 16,526,000 1,615,000 33,661,000 54,314,000 20,309,000 35,581,000 7,713,000 43,549,000 36,687,000 44,352,000 8,501,000 
      purchases of property and equipment
    		-1,188,000 -669,000 -1,297,000 -638,000 -1,505,000 -1,372,000 -1,690,000 -1,002,000 -500,000 -1,255,000 -4,100,000 -1,866,000 -2,211,000 -1,457,000 -635,000 -1,048,000 -1,284,000 -10,746,000 -12,588,000 -16,969,000 -22,191,000 
      capitalized internal-use software costs
    		-2,226,000 -2,074,000 -3,156,000 -2,131,000 -2,011,000 -1,919,000 -1,408,000 -1,375,000 -1,115,000 -1,977,000 -1,527,000 -821,000 -854,000 -882,000 0 -70,000      
      net cash from investing activities
    		42,632,000 9,276,000 -18,918,000 4,176,000 -26,340,000 41,516,000 56,000 -21,361,000 -18,930,000 -140,738,000 10,899,000 -140,366,000 30,596,000 51,977,000 -5,990,000 -12,091,000 5,313,000 19,161,000 9,538,000 -6,451,000 -41,666,000 
      cash flows from financing activities
    		                     
      repayment of term loan
    		0 -1,250,000   -625,000 -625,000   -625,000 -625,000 -1,250,000 -625,000 -35,666,000 -1,000,000 -1,000,000 -667,000 -500,000 -500,000 -500,000 -167,000  
      repurchases of common stock
    		-58,023,000 -30,785,000 -28,872,000 -14,526,000 -4,485,000 -54,847,000       -7,000 0   -4,000 0 -23,000 -13,000  
      proceeds from exercise of stock options
    		2,186,000 762,000 816,000 1,257,000 5,217,000 1,755,000 1,044,000 1,085,000 987,000 783,000 1,275,000 1,798,000 1,146,000 980,000 1,419,000 2,228,000 3,740,000 3,859,000 5,994,000 2,974,000 4,307,000 
      proceeds from employee stock purchase plan
    		0 5,266,000 0 7,746,000 0 4,799,000 0 8,866,000 0 6,511,000 0 8,558,000 1,000 7,959,000 0 9,156,000 0 7,223,000 0 6,127,000  
      taxes paid related to net share settlement of equity awards
    		    0 -1,000 0 -4,000 -3,000 0           0 
      net cash from financing activities
    		-55,837,000 -26,007,000 -30,556,000 -5,523,000 107,000 -48,919,000 -19,228,000 9,947,000 359,000 6,669,000 18,000 9,731,000 14,934,000 355,323,000 417,000 10,717,000 3,236,000 10,582,000 5,471,000 17,921,000 22,274,000 
      effect of foreign exchange rates on cash, cash equivalents, and restricted cash
    		1,990,000 -235,000 231,000 3,799,000 -1,846,000 -474,000    -3,081,000    -489,000        
      net increase in cash, cash equivalents, and restricted cash
    		   9,216,000          360,633,000   -31,415,000 1,503,000 6,382,000 4,055,000  
      cash, cash equivalents, and restricted cash
    		                     
      beginning of period
    		0 0 0 184,864,000 0 0 0 236,663,000 0 0 0 526,563,000 0 0 0 240,403,000 0 0 0 259,878,000 0 
      end of period
    		16,375,000 -794,000 -9,408,000 194,080,000 -12,224,000 -22,767,000 -2,194,000 222,049,000 -31,651,000 -145,383,000 31,463,000 382,234,000 15,973,000 360,633,000 -47,371,000 197,328,000 -31,415,000 1,503,000 6,382,000 263,933,000 -37,547,000 
      reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
    		                     
      cash and cash equivalents
    		                     
      restricted cash
    		                     
      total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows
    		                     
      supplemental cash flow data
    		                     
      cash paid for income taxes
    		                     
      cash paid for interest
    		                     
      supplemental non-cash investing and financing information
    		                     
      purchase of property and equipment in accounts payable and accrued expenses
    		                     
      vesting of early exercised stock options
    		                     
      stock-based compensation expense capitalized for software development
    		                     
      net decrease in cash, cash equivalents, and restricted cash
    		 -794,000    -22,767,000                
      net amortization of (discount) premium on marketable securities
    		                     
      proceeds from term loan, net of issuance costs
    		                0 0 0 9,000,000 18,000,000 
      proceeds from private placement—related party, net of offering costs
    		                     
      effect of foreign exchange rates on cash and cash equivalents
    		       -1,302,000    899,000    -568,000      
      net decrease in cash and cash equivalents
    		       -14,614,000              
      net amortization of premium (discount) on marketable securities
    		        -1,823,000 -636,000 -488,000 -444,000          
      amortization of discount on convertible notes and credit facility issuance costs
    		                     
      non-cash interest expense
    		                0 0 2,740,000 3,930,000 3,972,000 
      proceeds from private placement — related party, net of offering costs
    		                     
      net increase in cash and cash equivalents
    		           -144,329,000    -43,075,000      
      purchase of property and equipment in accounts payable and accrued liabilities
    		                     
      issuance of common stock upon conversion of convertible notes — related party
    		                     
      stock-based compensation for software development
    		                     
      allowance for doubtful accounts
    		               627,000 1,019,000 472,000 570,000 196,000 -280,000 
      net amortization of premium on marketable securities
    		            12,000 -7,000 2,000 55,000      
      amortization of discount on convertible notes and term loan issuance costs
    		            28,000 5,000 4,000 4,000 5,000 4,000 4,385,000 6,251,000 6,405,000 
      proceeds from issuance of convertible notes — related party
    		                    0 
      net amortization of premium (discount) of marketable securities
    		                     
      change in fair value of redeemable convertible preferred stock warrant liability
    		                     
      total cash, cash equivalents, and restricted cash
    		                     
      conversion of redeemable convertible preferred stock warrant liability to redeemable convertible preferred stock as a result of warrant exercise
    		                     
      loss on sale of property and equipment
    		                     
      accrued expenses and other current liabilities
    		                 -2,779,000 10,523,000 2,827,000 4,344,000 
      sales of property and equipment
    		                 2,000   0 
      capitalized internal-use software
    		                 -191,000 -113,000 -183,000 -104,000 
      proceeds from issuance of convertible notes—related party
    		                     
      effect of foreign exchange rates on cash and cash equivalents and restricted cash
    		                 260,000 -111,000 29,000 10,000 
      gain on sale of property and equipment
    		                    0 
      net accretion of discount of marketable securities
    		                     
      other liabilities
    		                     
      proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
    		                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.